This website uses cookies
More information
Business Air News Bulletin
Business Air News Bulletin
The monthly news publication for aviation professionals.

Why visit ACE ’24?

Related background information from the Handbook...
The monthly news publication for aviation professionals.

Request your printed copy

Tecnam develops TravelCare platform to shift vaccines
Equipped with Desmon's ultra-freezer designed to attain, maintain and track product temperature, Tecnam's P2012 TravelCare can transport as many as 115,000 vaccines to areas with short and unpaved runways.
The P2012 TravelCare platform is designed to maintain product temperatures at up to minus 86 degrees Celsius during transport.
Read this story in our January 2021 printed issue.

Italian aircraft manufacturer Tecnam has partnered with ultra-freezer manufacturer Desmon to repurpose its P2012 aircraft for COVID vaccine transportation. The platform, named P2012 TravelCare, was developed to help distributors worldwide reach remote and inaccessible communities, including areas with underdeveloped transport infrastructure, to ensure the timely and equitable delivery of the vaccine.

Equipped with Desmon's ultra-freezer designed to attain, maintain and track product temperature, Tecnam's P2012 TravelCare can transport as many as 115,000 doses to areas with less than 1,850ft of paved or unpaved runway.

The P2012 TravelCare platform is designed to maintain product temperatures at up to minus 86 degrees Celsius during transport, and minus 65 degrees for 10-12 hours after the system is unplugged for further distribution.

In addition to its reach and refrigeration capability, the P2012 TravelCare aircraft system can reduce the distribution cost to as little as USD 0.005 per dose, which is several orders of magnitude less when compared to the current means of transportation.

Tecnam MD Giovanni Pascale Langer says: “As the first vaccine breakthroughs were announced, we realised that communities in remote areas would face delays in receiving help. In Europe, 67 per cent of airports have runways shorter than 5,000ft, making them inaccessible to large aircraft.

“We decided to act fast. The P2012 TravelCare was designed to facilitate equitable and efficient vaccine distribution. It is our contribution to the fight for a COVID-free world. With the dedicated support of our partners at Desmon, we worked tirelessly to repurpose the P2012 aircraft and meet all the necessary regulations for this special mission within less than a month. The value of the P2012 platform will extend beyond this mission. Today, it will facilitate the vaccine transportation, and tomorrow it will continue to serve communities thanks to its versatility and easy configuration.”

Other News
 
Torres Strait Air becomes Australia launch customer for P2012
April 7, 2024
TSA will take delivery of two P2012s in May and June 2024, and has options for three STOL versions of the Traveller in a deal worth more than $14.5 million.
Tecnam P2012 STOL achieves EASA certification
March 28, 2024
The 18 months certification campaign ensured impressive take off and landing performance while maintaining a 99 per cent commonality of parts with the standard P2012 Traveller so as to enhance supportability.
Apex Aviation P2012 completes first year of medevac
March 14, 2024
Apex Aviation believes the P2012's spacious cabin and low operating costs set it apart, while advanced avionics provide the pilot with situational awareness not found in other last-gen competitors.